May 3, 2019

Oncolytics Biotech (R) Reports 2019 First Quarter Financial Results and Operational Highlights

Apr 25, 2019

Oncolytics Biotech(R) Announces Details of 2019 Annual General Meeting of Shareholders

Apr 23, 2019

Oncolytics Biotech(R) to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

Apr 8, 2019

Oncolytics Biotech(R) Announces First Patient Treated in Company's AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer

Apr 4, 2019

Oncolytics Biotech(R) to Host Key Opinion Leader Meeting on the Emerging Role of Biomarkers and Oncolytic Viruses in the Treatment of Cancer

Apr 3, 2019

Oncolytics Biotech(R) to Present at the 18th Annual Needham Healthcare Conference

Apr 2, 2019

Oncolytics Biotech (R) Presents Positive Clinical Biomarker Data at the American Association for Cancer Research Annual Meeting 2019

Mar 28, 2019

Oncolytics Biotech (R) Announces a Publication Highlighting Synergistic Effect of Pelareorep with a Proteasome Inhibitor in Preclinical Models of Multiple Myeloma

Mar 8, 2019

Oncolytics Biotech (R) Announces 2018 Year-End Results and Operational Highlights

Mar 1, 2019

Oncolytics Biotech(R) to Host Conference Call to Discuss Year End Financial Results and Operational Highlights